Stockscreener 앱 받기
114.50
1.34%
-1.55
시간 외 거래:
122.00
7.50
+6.55%
전일 마감가:
$116.05
열려 있는:
$115.5
하루 거래량:
714.40K
Relative Volume:
0.66
시가총액:
$3.90B
수익:
$401.09M
순이익/손실:
$32.64M
주가수익비율:
121.81
EPS:
0.94
순현금흐름:
$-120.51M
1주 성능:
-5.02%
1개월 성능:
-8.20%
6개월 성능:
+57.71%
1년 성능:
-29.26%
1일 변동 폭
$114.30
$118.68
1주일 범위
$114.30
$131.85
52주 변동 폭
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
명칭
Transmedics Group Inc
전화
(978) 552-0900
주소
200 MINUTEMAN ROAD, ANDOVER, MA
TMDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
114.50 | 4.05B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-22 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-29 | 재확인 | Needham | Buy |
| 2024-10-29 | 재확인 | Oppenheimer | Outperform |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-08-21 | 개시 | Needham | Buy |
| 2024-06-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-06-04 | 개시 | Stephens | Overweight |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2022-08-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2019-05-28 | 개시 | Canaccord Genuity | Buy |
| 2019-05-28 | 개시 | Cowen | Outperform |
| 2019-05-28 | 개시 | JP Morgan | Overweight |
| 2019-05-28 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Transmedics Group Inc 주식(TMDX)의 최신 뉴스
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect - ACCESS Newswire
When is the best time to buy TransMedics Group Inc. stockFree High Yield Stocks With Buy Confirmation - Newser
TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2025 Earnings Call Transcript - MSN
Why TransMedics Group Inc. is moving todayReal-Time Entry Signals for Top Stocks - Newser
Headlands Technologies LLC Has $562,000 Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Using data tools to time your TransMedics Group Inc. exitSmart Chart Forecasting with AI Algorithms - Newser
Developing predictive dashboards with TransMedics Group Inc. dataFree Early Breakout Entry Point Notifications - Newser
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Blair William & Co. IL - MarketBeat
TransMedics Group Inc. stock momentum explainedFree Trade Insight With Community Collaboration - Newser
Will TransMedics Group Inc. outperform the marketValue Investing Summary and Earnings Outlook - Newser
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
TransMedics Group Inc. stock trend forecastLong-Term Signal Tracking and Profit Summary - Newser
Can trapped investors hope for a rebound in TransMedics Group Inc.Trend Following Ideas with Volume Confirmation - Newser
Institutional scanner results for TransMedics Group Inc.Short Term Profit Strategy with Entry Cues - Newser
TransMedics Group CEO Makes Significant Stock Purchase, Boosting Investor Confidence - AInvest
Is TransMedics Group Inc. a candidate for recovery playFree Optimized Watchlist With Daily Adjustments - Newser
Why TransMedics Group Stocks Are Soaring - TipRanks
Applying Wyckoff theory to TransMedics Group Inc. stockFree Capital Efficiency Optimized Stock Alerts - Newser
CEO’s Bold Move: Major Stock Purchase Signals Confidence in TransMedics - TipRanks
TransMedics Sees Its Earnings Soar - AOL.com
TransMedics Group CEO Hassanein Waleed H buys 16835 shares at $118.68/share. - AInvest
TransMedics Group (NASDAQ:TMDX) Stock Price Up 6.8% on Analyst Upgrade - MarketBeat
Advanced analytics toolkit walkthrough for TransMedics Group Inc.Daily Market Entry Strategy with Tools - Newser
Exit strategy if you’re trapped in TransMedics Group Inc.Intelligent Trade Forecast With AI Analytics - Newser
Allianz Asset Management GmbH Takes Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Momentum divergence signals in TransMedics Group Inc. chartPrice Action Summary and Entry Strategy Guide - Newser
Live market analysis of TransMedics Group Inc.Entry Zone Forecast for Momentum Trading - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
How TransMedics Group Inc. stock performs during market volatilityEntry Opportunity Screener with Confirmation - Newser
Can TransMedics Group Inc. hit a new high this monthLong Hold Investment Strategy with Growth Focus - Newser
Why TransMedics (TMDX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Using Bollinger Bands to evaluate TransMedics Group Inc.Free Technical Entry Strategy for Beginners - Newser
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
TransMedics Group Director Sells $519,987 Worth of Stock Amid Positive Q2 Earnings and FDA Approval. - AInvest
TransMedics Group's Strategic Advancements and FDA Approval Boost Buy Rating - AInvest
XTX Topco Ltd Takes $1.30 Million Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Raised to "Buy" at Wall Street Zen - MarketBeat
TransMedics Group (NASDAQ:TMDX) Given New $123.00 Price Target at Morgan Stanley - MarketBeat
How high can TransMedics Group Inc. stock price go in 2025High Reward Picks with Tight Risk Control - Newser
Director Sells Over $500k in TransMedics Group Stock! - TipRanks
How to monitor TransMedics Group Inc. with trend dashboardsFree Investment Plan With Growth Optimization - Newser
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Group Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
FDA grants conditional approval for TransMedics’ OCS ENHANCE Heart trial - Yahoo Finance
TransMedics Group (NASDAQ:TMDX) Trading 6.8% Higher After Analyst Upgrade - Defense World
TransMedics Group, Inc. (NASDAQ:TMDX) Stock Position Lifted by HB Wealth Management LLC - MarketBeat
Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term - sharewise.com
TransMedics Stock Surges Following FDA Conditional Approval for Heart Trial - MSN
What analysts say about TransMedics Group Inc. stock outlookFree Daily Growth Stock Pick Reports - Newser
TransMedics Group (NASDAQ:TMDX) Shares Gap Up on Earnings Beat - MarketBeat
TransMedics Stock Surge: What’s Driving the Growth? - timothysykes.com
Transmedics Group Inc (TMDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):